Journal article

Global hepatitis C elimination: an investment framework

Alisa Pedrana, Jessica Howell, Nick Scott, Sophia Schroeder, Christian Kuschel, Jeffrey Lazarus, Rifat Atun, Ricardo Baptista-Leite, Ellen t'Hoen, Sharon J Hutchinson, Lisa Aufegger, Raquel Peck, Annette H Sohn, Tracy Swan, Mark Thursz, Olufunmilayo Lesi, Manik Sharma, John Thwaites, David P Wilson, Margaret Hellard

The Lancet Gastroenterology & Hepatology | ELSEVIER INC | Published : 2020

Abstract

WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of..

View full abstract

Grants

Awarded by Spanish Ministry of Science, Innovation and Universities through the Centro de Excelencia Severo Ochoa 2019-2023 Programme


Funding Acknowledgements

We would like to acknowledge the contributions of Mary Ribeiro Pombo (Imperial College London), M Walid Qoronfleh (World Innovation Summit for Health, Qatar), Deidre Thompson (Imperial College London and World Innovation Summit for Health), Gottfried Hirnschall (former Director of Department of HIV and Global Hepatitis Programme, WHO), Yvan Hutin (strategic information at the Global Hepatitis Programme, WHO Eastern Mediterranean Regional Office) and the World Innovation Summit for Health 2018 Viral Hepatitis Forum. The authors gratefully acknowledge funding from the Qatar Foundation, the support to the Burnet Institute provided by the Victorian Government Operational Infrastructure Support Program, and the contributions of Campbell Aitkin (Burnet Institute, VIC, Australia) for his role in the review and editing of this manuscript. JVL is supported by a Spanish Ministry of Science, Innovation, and Universities Miguel Servet grant and further acknowledges support from the Spanish Ministry of Science, Innovation and Universities through the Centro de Excelencia Severo Ochoa 2019-2023 Programme (CEX2018-000806-S), and from the Government of Catalonia through the Centres de Recerca de Catalunya. AP, JH, and MH are the recipients of National Health and Medical Research Council fellowships.